Using high throughput screening to define virus clearance by chromatography resins

Biotechnology and Bioengineering

Volumn 110, Issue 7, 2013, Pages 1984-1994

  Connell Crowley, Lisa ^a   Larimore, Elizabeth A ^a   Gillespie, Ron ^a  

^a AMGEN INC   (United States)

Author keywords

AEX chromatography; High throughput screening; Mixed mode chromatography; Virus clearance

Indexed keywords

CHROMATOGRAPHIC RESINS; DOWNSTREAM PROCESS DEVELOPMENT; EXPERIMENTAL CONDITIONS; HIGH THROUGHPUT SCREENING; MIXED-MODE CHROMATOGRAPHY; MURINE LEUKEMIA VIRUS; PROCESS-RELATED IMPURITIES; VIRUS CLEARANCE;

CELL CULTURE; IMPURITIES; REMOVAL; VIRUSES;

CHROMATOGRAPHY;

ANION EXCHANGE RESIN; SODIUM CHLORIDE;

ARTICLE; CHROMATOGRAPHY; CONCENTRATION (PARAMETERS); HIGH THROUGHPUT SCREENING; NONHUMAN; PH; VIRAL CLEARANCE;

ANIMALS; BIOTECHNOLOGY; CHO CELLS; CHROMATOGRAPHY; CRICETULUS; HIGH-THROUGHPUT SCREENING ASSAYS; HYDROGEN-ION CONCENTRATION; SALINITY; XENOTROPIC MURINE LEUKEMIA VIRUS-RELATED VIRUS;

RODENTIA; XENOTROPIC MURINE LEUKEMIA VIRUS;

EID: 84878394704     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.24869     Document Type: Article

References (41)

1. Anderson KP, Lie YS, Low MA, Williams SR, Wurm FM, Dinowitz M. 1991a. Defective endogenous retrovirus-like sequences and particles of Chinese hamster ovary cells. Dev Biol Stand 75:123-132.
2. Anderson KP, Low MA, Lie YS, Keller GA, Dinowitz M. 1991b. Endogenous origin of defective retrovirus-like particles from a recombinant Chinese hamster ovary cell line. Virology 181:305-311.
3. Bensch M, Wierling PS, von Lieres E, Hubbuch J. 2005. High throughput screening of chromatographic phases for rapid process development. Chem Eng Technol 28(11):1274-1284.
4. Bergander T, Nilsson-Valimaa K, Oberg K, Lacki KM. 2008. High-throughput process development: Determination of dynamic binding capacity using microtiter filter plates filled with chromatography resin. Biotechnol Prog 24:632-639.
5. Bhambure R, Kumar K, Rathore AS. 2011. High-throughput process development for biophamaceutical drug substances. Trends Biotechnol 29(3):127-135.
6. Brorson K. 2007. Advances in viral clearance. In: Shukla AA, Etzel M, Gadam S, editors. Process scale bioseparations for the biopharmaceutical industry. Boca Raton, FL: Taylor and Francis. p 449-462.
7. Brorson K, de Wit C, Hamilton E, Mustafa M, Swann PG, Kiss R, Taticek R, Polastri G, Stein KE, Xu Y. 2002. Impact of cell culture process changes on endogenous retrovirus expression. Biotechnol Bioeng 80(3):257-267.
8. Brorson K, Brown J, Hamilton E, Stein KE. 2003a. Identification of protein A media performance attributes that can be monitored as surrogates for retrovirus clearance during extended re-use. J Chromatogr A 989:155-163.
9. Brorson K, Krejci S, Lee K, Hamilton E, Stein K, Xu Y. 2003b. Bracketed generic inactivation of rodent retroviruses by low pH treatment for monoclonal antibodies and recombinant proteins. Biotechnol Bioeng 82:321-329.
10. Chen J, Tetrault J, Zhang Y, Wasserman A, Conley G, DiLeo M, Haimes E, Nixon AE, Ley A. 2010. The distinctive separation attributes of mixed-mode resins and their application in monoclonal antibody downstream purification process. J Chromatogr A 1217(2):216-224.
11. CHMP. 2009. Guideline of virus safety evaluation of biotechnological investigational medicinal products. In: Committee for medicinal products for human use EMA, editor. London. United Kingdom.
12. Coffman JL, Kramarczyk JF, Kelley BD. 2008. High-throughput screening of chromatographic separations: I. Method development and column modeling. Biotechnol Bioeng 100(4):605-618.
13. Connell-Crowley L, Nguyen T, Bach J, Chinniah S, Bashiri H, Gillespie R, Moscariello J, Hinckley P, Dehghani H, Vunnum S, Vedantham G. 2012. Cation exchange chromatography provides effective retrovirus clearance for antibody purification processes. Biotechnol Bioeng 109(1):157-165.
14. Curtis S, Lee K, Blank GS, Brorson K, Xu Y. 2003. Generic/matrix evaluation of SV40 clearance by anion exchange chromatography in flow-through mode. Biotechnol Bioeng 84(2):179-186.
15. FDA. 1997. Points to consider in the manufacture and testing of monoclonal antibody products for human use. In: Food and Drug Administration USDoHaHS, editor. Rockville, MD.
16. Gagnon P. 1996. Purification tools for monoclonal antibodies. Tucson, AZ: Validated Biosystems, Inc.
17. ICH. 1999. Q5A: Viral safety evaluation of biotechnological products derived from cell lines of human or animal origin. In: Use ICfHoTRfRoPfH, editor. Geneva, Switzerland.
18. ICH. 2009. Q8 (R1): Pharmaceutical Development Revision 1. In: Use ICfHoTRfRoPfH, editor. Geneva, Switzerland.
19. Kelley BD, Switzer M, Bastek P, Kramarczyk JF, Molnar K, Yu T, Coffman J. 2008a. High-throughput screening of chromatographic separations: IV. Ion-exchange. Biotechnol Bioeng 100(5):950-963.
20. Kelley BD, Tobler SA, Brown P, Coffman JL, Godavarti R, Iskra T, Switzer M, Vunnum S. 2008b. Weak partitioning chromatography for anion exchange purification of monoclonal antibodies. Biotechnol Bioeng 101:553-566.
21. Kramarczyk JF, Kelley BD, Coffman JL. 2008. High-throughput screening of chromatographic separations: II. Hydrophobic interaction. Biotechnol Bioeng 100(4):707-720.
22. Lacki KM. 2012. High-throughput process development of chromatography steps: Advantages and limitations of different formats used. Biotechnol J 7:1192-1202.
23. Lau AS, Lie YS, Norling LA, Sernatinger J, Dinowitz M, Petropoulos CJ, Xu Y. 1999. Quantitative competitive reverse transcription-PCR as a method to evaluate retrovirus removal during chromatography procedures. J Biotechnol 75(2-3):105-115.
24. Leiber MM, Benveniste RE, Livingston DM, Todaro GJ. 1973. Mammalian cells in culture frequently release type C viruses. Science 182:56-59.
25. Lute S, Norling L, Hanson M, Emery R, Stinson D, Padua D, Blank G, Chen Q, Brorson K. 2008. Robustness of virus removal by protein A chromatography is independent of media lifetime. J Chromatogr A 1205:17-25.
26. Miesegaes G, Lute S, Brorson K. 2010. Analysis of viral clearance unit operations for monoclonal antibodies. Biotechnol Bioeng 106(2):238-246.
27. Miesegaes G, Bailey M, Willkommen H, Chen Q, Roush D, Blümel J, Brorson K, editors. 2011. Proceedings of the 2009 Viral Clearance Symposium Developments in Biologicals 133.
28. Nfor BK, Noverraz M, Chilamkurthi S, Verhaert PDEM, van der Wielen LAM, Ottens M. 2010. High-throughput isotherm determination and thermodynamic modeling of protein adsorption on mixed mode adsorbents. J Chromatogr A 1217:6829-6850.
29. Norling L, Lute S, Emery R, Khuu W, Voisard M, Xu Y, Chen Q, Blank G, Brorson K. 2005. Impact of multiple re-use of anion exchange chromatography media on virus removal. J Chromatogr A 1069:79-89.
30. Pezzini J, Joucla G, Gantier R, Toueille M, Lomenech A-M, Le Sénéchal C, Garbay B, Santarelli X, Cabanne C. 2011. Antibody capture by mixed-mode chromatography: A comprehensive study from determination of optimal purification conditions to identification of contaminating host cell proteins. J Chromatogr A 1218(45):8197-8208.
31. Sanaie N, Cecchini D, Pieracci J. 2012. Applying high-throughput methods to develop a purification process for a highly glycosylated protein. Biotechnol J 7:1242-1255.
32. Shi L, Chen Q, Norling LA, Lau AS, Krejci S, Xu Y. 2004. Real time quantitative PCR as a method to evaluate xenotropic murine leukemia virus removal during pharmaceutical protein purification. Biotechnol Bioeng 87(7):884-896.
33. Shukla AA, Hubbard B, Tressel T, Guhan S, Low D. 2007. Downstream processing of monoclonal antibodies-Application of platform approaches. J Chromatogr B 848(1):28-39.
34. Strauss DM, Gorrell J, Plancarte M, Blank G, Chen Q, Yang B. 2009a. Anion exchange chromatography provides a robust, predictible process to ensure viral safety of biotechnology products. Biotechnol Bioeng 102(1):168-175.
35. Strauss DM, Lute S, Brorson K, Blank GS, Chen Q, Yang B. 2009b. Removal of endogenous retrovirus-like particles from CHO-cell derived products using Q sepharose fast flow chromatography. Biotechnol Progress 25(4):1194-1197.
36. Strauss DM, Lute S, Tebaykina Z, Frey DD, Ho C, Blank GS, Brorson K, Chen Q, Yang B. 2009c. Understanding the mechanism of virus removal by Q sepharose fast flow chromatography during the purification of CHO-cell derived biotherapeutics. Biotechnol Bioeng 104(2):371-380.
37. Strauss DM, Cano T, Cai N, Delucchi H, Plancarte M, Coleman D, Blank GS, Chen Q, Yang B. 2010. Strategies for developing design spaces for viral clearance by anion exchange chromatography during monoclonal antibody production. Biotechnol Progress 26(3):750-755.
38. Susanto A, Knieps-Grunhagen E, von Lieres E, Hubbuch J. 2008. High throughput screening for the design and optimization of chromatographic processes: Assessment of model parameter determination from high throughput compatable data. Chem Eng Technol 31(12):1846-1855.
39. Wensel DL, Kelley BD, Coffman JL. 2008. High-throughput screening of chromatographic separations: III. Monoclonal antibodies on ceramic hydroxyapatite. Biotechnol Bioeng 100:839-854.
40. Wiendahl M, Wierling PS, Nielsen J, Christensen DF, Krarup J, Staby A, Hubbuch J. 2008. High throughput screening for the design and optimization of chromatographic processes-Miniaturization, automation and parallelization of breakthrough and elution studies. Chem Eng Technol 31(6):893-903.
41. Zhang M, Lute S, Norling L, Hong C, Safta A, O'Connor D, Bernstein LJ, Wang H, Blank G, Brorson K, et al. 2009. A novel, Q-PCR based approach to measuring endogenous retroviral clearance by capture protein A chromatography. Biotechnol Bioeng 102(5):1438-1447.